Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Ross

Showing results (171-180 of 345) with videos related to

Pageof 35
Sort By:
The Journal of Infectious Diseases|December 20, 2014
Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilitiesDavid A Nace, Chyongchiou Jeng Lin, Ted M Ross, et al.
Journal of Proteome Research|June 27, 2022
Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement PathwayRui Qin, Guanmin Meng, Smruti Pushalkar, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccinationDavid Forgacs, Vanessa S Moraes, Hannah B Hanley, et al.
Plos One|June 26, 2009
A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferretsTed M Ross, Kutub Mahmood, Corey J Crevar, et al.
Journal of Clinical Microbiology|January 27, 2026
Emergence of influenza A(H3N2) subclade K in northeast Ohio in autumn 2025Xuan Xu, William Hull, David Plunkett, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodiesKelly R Young, Benjamin E Teal, Yvonne Brooks, et al.
Brain Pathology (Zurich, Switzerland)|July 1, 2011
Acute murine H5N1 influenza A encephalitisStephanie J Bissel, Brendan M Giles, Guoji Wang, et al.
Vaccine|October 4, 2011
Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged miceKirsten Schneider-Ohrum, Brendan M Giles, Heather K Weirback, et al.
NPJ Vaccines|October 25, 2024
Interferon as an immunoadjuvant to enhance antibodies following influenza B infection and vaccination in ferretsThomas Rowe, Ashley Fletcher, Pavel Svoboda, et al.
International Journal of Pharmaceutics|November 27, 2022
Sustained delivery of CpG oligodeoxynucleotide by acetalated dextran microparticles augments effector response to Computationally Optimized Broadly Reactive Antigen (COBRA) influenza hemagglutininCole J Batty, Eva A Amouzougan, Michael A Carlock, et al.
Pageof 35

Showing results (171-180 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Infectious Diseases|December 20, 2014
Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilitiesDavid A Nace, Chyongchiou Jeng Lin, Ted M Ross, et al.
Journal of Proteome Research|June 27, 2022
Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement PathwayRui Qin, Guanmin Meng, Smruti Pushalkar, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccinationDavid Forgacs, Vanessa S Moraes, Hannah B Hanley, et al.
Plos One|June 26, 2009
A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferretsTed M Ross, Kutub Mahmood, Corey J Crevar, et al.
Journal of Clinical Microbiology|January 27, 2026
Emergence of influenza A(H3N2) subclade K in northeast Ohio in autumn 2025Xuan Xu, William Hull, David Plunkett, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodiesKelly R Young, Benjamin E Teal, Yvonne Brooks, et al.
Brain Pathology (Zurich, Switzerland)|July 1, 2011
Acute murine H5N1 influenza A encephalitisStephanie J Bissel, Brendan M Giles, Guoji Wang, et al.
Vaccine|October 4, 2011
Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged miceKirsten Schneider-Ohrum, Brendan M Giles, Heather K Weirback, et al.
NPJ Vaccines|October 25, 2024
Interferon as an immunoadjuvant to enhance antibodies following influenza B infection and vaccination in ferretsThomas Rowe, Ashley Fletcher, Pavel Svoboda, et al.
International Journal of Pharmaceutics|November 27, 2022
Sustained delivery of CpG oligodeoxynucleotide by acetalated dextran microparticles augments effector response to Computationally Optimized Broadly Reactive Antigen (COBRA) influenza hemagglutininCole J Batty, Eva A Amouzougan, Michael A Carlock, et al.
Pageof 35